Targeting heme-oxidised/heme-free soluble guanylyl cyclise to identify diabetic patients at risk of development of vascular disease.

  • Drummond, Grant (Primary Chief Investigator (PCI))
  • Harper, Barbara (Chief Investigator (CI))
  • Schmidt, Harald (Chief Investigator (CI))
  • Teede, Helena (Chief Investigator (CI))
  • Wu, Michael Siu Hang (Chief Investigator (CI))
  • Zoungas, Sophia (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/08 → 31/12/08

Funding

  • Diabetes Australia: A$51,943.00